Brown-Forman's Q2 Profit Dips Amid Restructuring, Sales Decline
Ticker: BF-B · Form: 10-Q · Filed: Dec 4, 2025 · CIK: 14693
Sentiment: bearish
Topics: Spirits Industry, Earnings Decline, Restructuring, Cost Reduction, Shareholder Value, Liquor Market, Financial Performance
TL;DR
**BF-B is struggling with declining sales and profits, and while restructuring is underway, it's a 'wait and see' if it pays off.**
AI Summary
Brown-Forman Corporation reported a decline in net income and net sales for the three and six months ended October 31, 2025. For the three months, net income decreased to $224 million from $258 million in the prior year, a 13.2% drop, while net sales fell to $1,036 million from $1,095 million, a 5.4% decrease. Over the six-month period, net income was $394 million, down from $453 million (13.0% decrease), and net sales were $1,960 million, a 4.2% reduction from $2,046 million. The company initiated a Restructuring Initiative on January 13, 2025, to reduce its structural cost base, including a 12% reduction in worldwide headcount and the closure of its Louisville-based Brown-Forman Cooperage. This initiative incurred $16 million in charges for the six months ended October 31, 2025. The sale of the Brown-Forman Cooperage facility on May 1, 2025, generated $33 million in cash and an $88 million non-cash supply contract. Diluted earnings per share decreased to $0.47 for the three months and $0.83 for the six months ended October 31, 2025, compared to $0.55 and $0.96, respectively, in the prior year. The company also saw an increase in treasury stock acquisition, spending $99 million for the six months ended October 31, 2025.
Why It Matters
Brown-Forman's declining net sales and net income signal potential headwinds for investors, suggesting a need for closer scrutiny of its market position and brand strength in a competitive spirits industry. The significant restructuring, including a 12% headcount reduction and cooperage closure, indicates management's aggressive efforts to streamline operations and improve efficiency, which could impact employee morale and local economies in the short term. For customers, these changes might not be immediately visible, but cost-cutting measures could influence product availability or pricing strategies in the long run. The competitive landscape, with rivals potentially gaining market share, makes Brown-Forman's ability to execute its strategic outlook crucial for its future valuation and market standing.
Risk Assessment
Risk Level: medium — The company reported a 13.0% decrease in net income to $394 million for the six months ended October 31, 2025, and a 4.2% decline in net sales to $1,960 million for the same period. This consistent decline, coupled with ongoing restructuring charges of $16 million, indicates operational challenges and potential market share erosion, warranting a medium risk assessment.
Analyst Insight
Investors should monitor the effectiveness of Brown-Forman's Restructuring Initiative and its impact on future financial performance. A 'hold' position is advisable until there's clear evidence that cost-cutting measures translate into improved profitability and sales growth, especially given the current declines.
Financial Highlights
- debt To Equity
- 0.50
- revenue
- $1,036 million
- operating Margin
- 29.4%
- total Assets
- $8,221 million
- total Debt
- $2,419 million
- net Income
- $224 million
- eps
- $0.47
- gross Margin
- 59.3%
- cash Position
- $319 million
- revenue Growth
- -5.4%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Net Sales | $1,036 million | -5.4% |
| Net Sales | $1,960 million | -4.2% |
Key Numbers
- $1,036 million — Net sales for three months ended Oct 31, 2025 (Decreased from $1,095 million in prior year)
- $224 million — Net income for three months ended Oct 31, 2025 (Decreased from $258 million in prior year)
- $1,960 million — Net sales for six months ended Oct 31, 2025 (Decreased from $2,046 million in prior year)
- $394 million — Net income for six months ended Oct 31, 2025 (Decreased from $453 million in prior year)
- $0.47 — Diluted EPS for three months ended Oct 31, 2025 (Decreased from $0.55 in prior year)
- $0.83 — Diluted EPS for six months ended Oct 31, 2025 (Decreased from $0.96 in prior year)
- $16 million — Restructuring and other charges (Incurred for six months ended Oct 31, 2025)
- 12% — Worldwide headcount reduction (Part of the Restructuring Initiative)
- $33 million — Cash proceeds from cooperage sale (Received on May 1, 2025)
- $88 million — Non-cash consideration from cooperage sale (Related to a supply contract)
Key Players & Entities
- BROWN FORMAN CORP (company) — Registrant
- The Duckhorn Portfolio, Inc. (company) — Acquired Sonoma-Cutrer wine business
- Butterfly Equity (company) — Acquired Duckhorn
- Louisville (person) — Location of Brown-Forman Cooperage
- FASB (regulator) — Financial Accounting Standards Board
- SEC (regulator) — U.S. Securities and Exchange Commission
- New York Stock Exchange (regulator) — Exchange where BF-B is listed
FAQ
What were Brown-Forman's net sales for the quarter ended October 31, 2025?
Brown-Forman's net sales for the three months ended October 31, 2025, were $1,036 million, a decrease from $1,095 million in the same period of the prior year.
How did Brown-Forman's net income change for the six months ended October 31, 2025?
For the six months ended October 31, 2025, Brown-Forman's net income decreased to $394 million from $453 million in the prior year, representing a 13.0% decline.
What is the purpose of Brown-Forman's Restructuring Initiative?
The Restructuring Initiative, approved on January 13, 2025, aims to reduce Brown-Forman's structural cost base and realign resources towards future growth, including a 12% reduction in worldwide headcount and the closure of the Louisville-based Brown-Forman Cooperage.
What were the total restructuring charges incurred by Brown-Forman through October 31, 2025?
Through October 31, 2025, Brown-Forman recognized $64 million in restructuring and other charges associated with the Restructuring Initiative, comprising $62 million in restructuring charges and $2 million in asset impairments.
What was the impact of the Brown-Forman Cooperage sale on the company?
The sale of the Brown-Forman Cooperage facility on May 1, 2025, generated $33 million in cash and an $88 million non-cash supply contract. The company recognized an immaterial pre-tax gain from this transaction.
How did diluted earnings per share change for Brown-Forman?
Diluted earnings per share for Brown-Forman decreased to $0.47 for the three months ended October 31, 2025, from $0.55 in the prior year, and to $0.83 for the six months ended October 31, 2025, from $0.96.
What is Brown-Forman's outlook on the new FASB accounting standards?
Brown-Forman is evaluating the impact of new FASB accounting standards for income tax disclosures (due April 30, 2026) and expense disaggregation (due April 30, 2028), but does not expect the income tax standard to have a material impact on its financial position or results of operations.
What was the change in Brown-Forman's cash and cash equivalents?
Brown-Forman's cash and cash equivalents decreased by $125 million for the six months ended October 31, 2025, ending the period with $319 million, down from $444 million at April 30, 2025.
What are the primary risks associated with Brown-Forman's current financial performance?
The primary risks include sustained declines in net sales and net income, the execution risk of the Restructuring Initiative, and potential competitive pressures in the spirits market, which could further impact profitability and market share.
How much did Brown-Forman spend on treasury stock acquisition?
Brown-Forman spent $99 million on the acquisition of treasury stock for the six months ended October 31, 2025, contributing to a total treasury stock value of $700 million.
Risk Factors
- Restructuring and Cost Reduction [medium — operational]: The company initiated a Restructuring Initiative on January 13, 2025, involving a 12% worldwide headcount reduction and the closure of the Louisville-based Brown-Forman Cooperage. This initiative incurred $16 million in charges for the six months ended October 31, 2025.
- Cooperage Sale and Supply Chain [medium — operational]: The sale of the Brown-Forman Cooperage facility on May 1, 2025, generated $33 million in cash and an $88 million non-cash supply contract. This impacts the company's internal supply chain for barrels.
- Sales Decline [medium — market]: Net sales decreased by 5.4% to $1,036 million for the three months and 4.2% to $1,960 million for the six months ended October 31, 2025, indicating potential market challenges or shifts in consumer demand.
- Decreased Profitability [medium — financial]: Net income fell 13.2% to $224 million for the three months and 13.0% to $394 million for the six months ended October 31, 2025, impacted by restructuring charges and sales declines.
- Increased Treasury Stock [low — financial]: The company increased its acquisition of treasury stock, spending $99 million for the six months ended October 31, 2025, which reduces cash available for other investments or debt reduction.
Industry Context
The spirits industry is characterized by strong brand loyalty, premiumization trends, and increasing competition from both established players and emerging craft distilleries. Regulatory environments vary significantly by market, impacting distribution and marketing. Economic conditions and consumer discretionary spending also play a crucial role in sales performance.
Regulatory Implications
Brown-Forman operates in a highly regulated industry, with significant oversight on alcohol production, marketing, and sales. Changes in excise taxes, advertising restrictions, or trade policies in key markets could materially impact financial results and operational strategies.
What Investors Should Do
- Monitor the impact of the Restructuring Initiative
- Evaluate the long-term strategy post-cooperage sale
- Analyze the drivers of the net sales decline
- Observe future share repurchase activity
Key Dates
- 2025-01-13: Restructuring Initiative Launched — This initiative aims to reduce structural costs, including significant headcount reduction and facility closure, impacting current financial performance and future operational efficiency.
- 2025-05-01: Brown-Forman Cooperage Facility Sold — The sale generated $33 million in cash and an $88 million non-cash supply contract, altering the company's asset base and supply chain arrangements.
- 2025-10-31: End of Second Quarter and Six-Month Period — Reporting period for the financial results showing declines in net sales and net income, alongside restructuring charges.
Glossary
- Net sales
- The total revenue generated from sales after deducting returns, allowances, and discounts. (Key indicator of the company's top-line performance and market demand for its products.)
- Restructuring and other charges
- Costs incurred due to significant organizational changes, such as layoffs, facility closures, or business realignments. (These charges directly impact net income and reflect strategic decisions impacting the company's cost structure.)
- Treasury stock
- Shares of a company's own stock that it has repurchased from the open market. (Acquisition of treasury stock reduces the number of outstanding shares and can be used for stock-based compensation or to return capital to shareholders.)
- Diluted earnings per share (EPS)
- A measure of profitability that divides net income by the total number of outstanding shares, including all dilutive potential common shares. (Provides a more conservative view of profitability on a per-share basis, reflecting the impact of all potential share issuances.)
- Assets held for sale
- Assets that management has committed to selling and are available for immediate sale in their present condition. (Indicates assets that are no longer part of the company's ongoing operations and are expected to be disposed of.)
Year-Over-Year Comparison
Compared to the prior year's periods, Brown-Forman experienced a notable decline in financial performance. Net sales for the three months ended October 31, 2025, fell 5.4% to $1,036 million, and for the six months, they decreased 4.2% to $1,960 million. Net income also saw significant drops, down 13.2% to $224 million for the quarter and 13.0% to $394 million for the six months. Diluted EPS followed suit, decreasing from $0.55 to $0.47 for the quarter and $0.96 to $0.83 for the six months. The company also incurred $16 million in restructuring charges, a significant increase from $2 million in the prior year's six-month period, contributing to the reduced profitability.
Filing Stats: 4,903 words · 20 min read · ~16 pages · Grade level 14.5 · Accepted 2025-12-04 16:09:14
Key Financial Figures
- $0.15 — istered Class A Common Stock (voting), $0.15 par value BFA New York Stock Exchange
Filing Documents
- bfb-20251031.htm (10-Q) — 1312KB
- bfb-10312025xex311evergreen.htm (EX-31.1) — 10KB
- bfb-10312025xex312evergreen.htm (EX-31.2) — 10KB
- bfb-10312025xex32evergreen.htm (EX-32) — 9KB
- 0000014693-25-000112.txt ( ) — 7543KB
- bfb-20251031.xsd (EX-101.SCH) — 43KB
- bfb-20251031_cal.xml (EX-101.CAL) — 72KB
- bfb-20251031_def.xml (EX-101.DEF) — 233KB
- bfb-20251031_lab.xml (EX-101.LAB) — 578KB
- bfb-20251031_pre.xml (EX-101.PRE) — 413KB
- bfb-20251031_htm.xml (XML) — 1302KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION 3
Financial Statements (Unaudited)
Item 1. Financial Statements (Unaudited) 3
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 20
Quantitative and Qualitative Disclosures about Market Risk
Item 3. Quantitative and Qualitative Disclosures about Market Risk 36
Controls and Procedures
Item 4. Controls and Procedures 36
- OTHER INFORMATION
PART II - OTHER INFORMATION 37
Legal Proceedings
Item 1. Legal Proceedings 37
Risk Factors
Item 1A. Risk Factors 37
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 37
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 37
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 37
Other Information
Item 5. Other Information 37
Exhibits
Item 6. Exhibits 38
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
Financial Statements (Unaudited)
Item 1. Financial Statements (Unaudited) BROWN-FORMAN CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Dollars in millions, except per share amounts) Three Months Ended Six Months Ended October 31, October 31, 2024 2025 2024 2025 Sales $ 1,376 $ 1,336 $ 2,587 $ 2,527 Excise taxes 281 300 541 567 Net sales 1,095 1,036 2,046 1,960 Cost of sales 449 421 835 793 Gross profit 646 615 1,211 1,167 Advertising expenses 126 126 252 246 Selling, general, and administrative expenses 185 187 373 364 Restructuring and other charges 2 4 2 16 Other expense (income), net ( 8 ) ( 7 ) ( 38 ) ( 24 ) Operating income 341 305 622 565 Non-operating postretirement expense 1 3 1 22 Interest income ( 3 ) ( 3 ) ( 7 ) ( 7 ) Interest expense 32 26 64 51 Equity method investment income ( 2 ) — ( 2 ) — Income before income taxes 313 279 566 499 Income taxes 55 55 113 105 Net income $ 258 $ 224 $ 453 $ 394 Earnings per share: Basic $ 0.55 $ 0.47 $ 0.96 $ 0.83 Diluted $ 0.55 $ 0.47 $ 0.96 $ 0.83 See notes to the condensed consolidated financial statements. 3 BROWN-FORMAN CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (Dollars in millions) Three Months Ended Six Months Ended October 31, October 31, 2024 2025 2024 2025 Net income $ 258 $ 224 $ 453 $ 394 Other comprehensive income (loss), net of tax: Currency translation adjustments ( 26 ) 9 ( 68 ) 34 Cash flow hedge adjustments ( 1 ) 2 ( 3 ) 4 Postretirement benefits adjustments — 3 1 12 Net other comprehensive income (loss) ( 27 ) 14 ( 70 ) 50 Comprehensive income $ 231 $ 238 $ 383 $ 444 See notes to the condensed consolidated financial statements. 4 BROWN-FORMAN CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Dollars in millions, except per share amounts) April 30, 2025 October 31, 2025 Assets Cash and cash equivalents $ 444 $ 319 Accounts receivable, less allow